MX2018011620A - Nanocapsulas de ingrediente activo liposoluble, fabricacion y usos de las mismas. - Google Patents

Nanocapsulas de ingrediente activo liposoluble, fabricacion y usos de las mismas.

Info

Publication number
MX2018011620A
MX2018011620A MX2018011620A MX2018011620A MX2018011620A MX 2018011620 A MX2018011620 A MX 2018011620A MX 2018011620 A MX2018011620 A MX 2018011620A MX 2018011620 A MX2018011620 A MX 2018011620A MX 2018011620 A MX2018011620 A MX 2018011620A
Authority
MX
Mexico
Prior art keywords
nanocapsules
production
active ingredient
liposoluble active
relates
Prior art date
Application number
MX2018011620A
Other languages
English (en)
Inventor
Preveraud Damien
Rosilio Véronique
Original Assignee
Adisseo France Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adisseo France Sas filed Critical Adisseo France Sas
Publication of MX2018011620A publication Critical patent/MX2018011620A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Abstract

La invención se refiere a nanocápsulas en forma de una suspensión coloidal o en forma seca, dichas nanocápsulas comprendiendo al menos un ingrediente activo en forma de un aceite, un tensioactivo iónico, opcionalmente un tensioactivo no iónico y un polímero hidrófilo. La invención también se refiere a su fabricación y sus usos.
MX2018011620A 2016-03-25 2017-03-17 Nanocapsulas de ingrediente activo liposoluble, fabricacion y usos de las mismas. MX2018011620A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1652592 2016-03-25
PCT/FR2017/050622 WO2017162963A1 (fr) 2016-03-25 2017-03-17 Nanocapsules de principe actif liposoluble, fabrication et utilisations

Publications (1)

Publication Number Publication Date
MX2018011620A true MX2018011620A (es) 2019-03-14

Family

ID=56263861

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011620A MX2018011620A (es) 2016-03-25 2017-03-17 Nanocapsulas de ingrediente activo liposoluble, fabricacion y usos de las mismas.

Country Status (13)

Country Link
US (1) US10765639B2 (es)
EP (1) EP3432729A1 (es)
JP (1) JP2019513359A (es)
KR (1) KR20180128025A (es)
CN (1) CN108882729A (es)
AU (1) AU2017236312B2 (es)
BR (1) BR112018069392B1 (es)
CA (1) CA3017931C (es)
MX (1) MX2018011620A (es)
RU (1) RU2745844C2 (es)
UA (1) UA127243C2 (es)
WO (1) WO2017162963A1 (es)
ZA (1) ZA201806197B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102370217B1 (ko) * 2019-11-27 2022-03-07 군산대학교 산학협력단 유자 오일을 포함하는 나노복합체의 제조방법
RU2736051C1 (ru) * 2020-03-04 2020-11-11 Александр Александрович Кролевец Способ получения нанокапсул сухого экстракта эхинацеи
RU2743010C1 (ru) * 2020-03-23 2021-02-12 Таисия Скандарбековна Гутнова Способ получения нанокапсул витамина D3
CN114847488A (zh) * 2022-05-17 2022-08-05 江南大学 一种高稳定性和生物可给率的橘味维生素a-维生素d纳米复合载体制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788007B1 (fr) * 1999-01-05 2001-02-09 Oreal Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
FR2803203B1 (fr) * 1999-12-31 2002-05-10 Fournier Ind & Sante Nouvelles formulations galeniques du fenofibrate
FR2806005B1 (fr) * 2000-03-10 2002-06-14 Univ Claude Bernard Lyon Procede de preparation de particules colloidales sous forme de nanocapsules
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP2005028559A (ja) * 2003-07-08 2005-02-03 Shinobu Ito ナノカプセル
FR2864900B1 (fr) * 2004-01-09 2007-10-12 Oreal Dispersion aqueuse de nanocapsules a coeur huileux
EP1937204B1 (en) * 2005-10-18 2018-07-25 Amorepacific Corporation Cationic polymer nanoparticles encapsulating an active ingredients, and the cosmetic composition containing the same
ATE515260T1 (de) * 2006-03-13 2011-07-15 Advanced In Vitro Cell Technologies S L Stabile nanokapselsysteme für die verabreichung von wirkstoffen
FR2924943A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition dermatologique comprenant des nanocapsules polymeriques de calcitriol, son procede de preparation et son utilisation
BRPI0805854A2 (pt) * 2008-10-10 2010-08-24 Biolab Sanus Farmaceutica Ltda sistema nanoparticulado, processo de preparaÇço do mesmo, uso do mesmo, composiÇço fotoproterora, processo de preparaÇço da mesma, mÉtodo de prevenÇço de doenÇas e distérbios da pele
BRPI1014276B8 (pt) * 2009-04-24 2021-05-25 Iceutica Pty Ltd produção de nanopartículas encapsuladas em escala comercial
EP2266546A1 (en) * 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
ES2351756B1 (es) * 2009-07-28 2011-10-05 Universidad Del Pais Vasco Nanopartículas lipídicas para terapia génica.
CA2843943A1 (en) * 2014-02-20 2014-05-28 Pankaj Modi Oral formulations of chemotherapeutic agents
RU2557900C1 (ru) * 2014-03-25 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул витаминов
WO2017021983A1 (en) * 2015-08-06 2017-02-09 Rubicon Research Private Limited Particulate delivery systems

Also Published As

Publication number Publication date
RU2018135575A (ru) 2020-04-27
WO2017162963A1 (fr) 2017-09-28
BR112018069392B1 (pt) 2022-11-22
UA127243C2 (uk) 2023-06-21
CN108882729A (zh) 2018-11-23
JP2019513359A (ja) 2019-05-30
CA3017931C (fr) 2024-01-09
US10765639B2 (en) 2020-09-08
RU2018135575A3 (es) 2020-06-09
RU2745844C2 (ru) 2021-04-01
BR112018069392A2 (pt) 2019-01-22
CA3017931A1 (fr) 2017-09-28
ZA201806197B (en) 2019-06-26
AU2017236312A1 (en) 2018-10-18
US20190083414A1 (en) 2019-03-21
KR20180128025A (ko) 2018-11-30
AU2017236312B2 (en) 2021-02-04
EP3432729A1 (fr) 2019-01-30

Similar Documents

Publication Publication Date Title
MX2018011620A (es) Nanocapsulas de ingrediente activo liposoluble, fabricacion y usos de las mismas.
USD861316S1 (en) Shoe side
MX2019006868A (es) Derivados de polisacáridos anfifílicos y composiciones que los comprenden.
MX2019006699A (es) Composiciones de methylobacterium para control de enfermedades fúngicas.
WO2017100063A3 (en) Stable ready-to-drink beverage compositions comprising lipophilic active agents
BR112018011501A2 (pt) copolímeros em bloco de formação de camada de polieletrólito e composições e usos dos mesmos
WO2017002115A3 (en) Hybrid nanoparticles as photoinitiators
EP3273079A4 (en) Electromagnetically enabled active type dynamic gas bearing
WO2016201284A3 (en) Antifungal methylobacterium compositions and methods of use
USD993603S1 (en) Shoe upper
WO2016195311A3 (ko) 그래핀 분산안정제용 합성수용성고분자, 그 고분자를 포함하는 고안정성 콜로이드 그래핀용액, 그 그래핀용액을 포함하는 그래핀하이드로겔 및 그래핀에어로겔
WO2017096330A3 (en) Electronically connected environment
WO2017087916A3 (en) Thermostable glucose biosensors and uses thereof
WO2016059019A3 (en) Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use
SG10201908628QA (en) A stent assembly and method of preparing the stent assembly
WO2017023407A3 (en) Nanobiocomposite compositions and methods
WO2016063119A8 (en) Oil-in-water nanoemulsions
USD821725S1 (en) Footwear
PH12016500855A1 (en) Pharmaceutical preparation and method of its production and use
WO2016016518A3 (fr) Dérivés de stérols pour le traitement de la perte auditive neurosensorielle et composition correspondante
CA3063204A1 (en) Clotting factor variants and their use
MX2018012311A (es) Composicion oftalmica que comprende pvp-i.
RU2018104322A (ru) Штамм Lactobacillus fermentum U-21 продуцирующий комплекс биологически активных веществ, осуществляющих нейтрализацию супероксид-аниона, индуцируемого химическими агентами
JP2016148076A5 (es)
FR3024733B1 (fr) Agent epaississant pour systemes aqueux, formulations le contenant et utilisations.